ActiPatch® in Clinical PEMF Research
Musculoskeletal Clearance Trials – Knee & Cervical (Neck) Arthritis
ActiPatch’s FDA Musculoskeletal Clearance is based on two key arthritis trials -
ActiPatch effectiveness in reducing arthritis pain was validated by both studies.
Large-Scale Registry Study
BioElectronics’ 7-day trial included 44,000+ users across UK and Ireland
Of 5,000 chronic pain sufferers who reported outcomes:
65% showed 57% average pain reduction
67% of opioid users reduced or discontinued medication
84% reported improved quality of life
93% confirmed long-term effectiveness
Additional Indications Studied
Plantar Fasciitis: Multicenter, double-blind trial showed overnight use reduced heel pain (Journal of Foot and Ankle Surgery)
Italian carpal tunnel study (published 3-2-25):
Results - All patients showed an improvement in pain level and functional capacity after using ActiPatch for pillar pain management. Additionally, none of the patients experienced pillar pain during the subsequent preventive phase.
Conclusion - The use of ActiPatch proves to be a viable and effective approach for managing and preventing pillar pain in elderly patients with weight-bearing hands who have undergone carpal tunnel release surgery.
Bottom Line
PEMF therapy continues to show strong promise for arthritis, including knee, neck, and potentially thumb CMC joints. ActiPatch remains a cost-effective, wearable option with well-established safety and efficacy across trials. For those seeking deeper tissue effects or specialized programs, alternatives like FlexPulse or NeoRhythm may offer additional value.
How ActiPatch Compares to Other PEMF Devices
ActiPatch ($30–$50)
Wearable, low-intensity PEMF device
Frequency: 1 kHz pulses at 27.12 MHz
Intensity: Very low (microtesla range)
Use Case: Chronic pain, arthritis, plantar fasciitis
Pros:
FDA-cleared for musculoskeletal pain
Affordable and easy to use
Long battery life (up to 720 hours)
Cons:
Limited intensity and depth of penetration
Disposable after battery life ends
FlexPulse ($500–$700)
Localized PEMF device with multiple frequency programs
Frequency Range: 0.5 Hz to 100 Hz
Intensity: Up to 300 Gauss
Pros:
Customizable for different conditions
Rechargeable and portable
Stronger electromagnetic field allows deeper tissue penetration
Cons:
Higher cost
Requires setup and understanding of its programming options
Oska Pulse ($300–$400)
Wearable PEMF device with a single automated healing program
Frequency: Varies through four stages
Intensity: ~9 Gauss
Pros:
Easy, one-button operation
Addresses inflammation, pain, blood flow, and healing
Registered as a medical device in multiple countries
Cons:
Lower intensity than FlexPulse
Pricier than ActiPatch
NeoRhythm ($300–$400)
Head-worn PEMF device focused on neurological health
Use Case: Sleep, focus, meditation, cognitive enhancement
Pros:
Controlled via mobile app with multiple brainwave frequency programs
Innovative design for cognitive support
Cons:
Not ideal for musculoskeletal pain
May be uncomfortable to wear while sleeping
Musculoskeletal Clearance Trials – Knee & Cervical (Neck) Arthritis
ActiPatch’s FDA Musculoskeletal Clearance is based on two key arthritis trials -
ActiPatch effectiveness in reducing arthritis pain was validated by both studies.
Large-Scale Registry Study
BioElectronics’ 7-day trial included 44,000+ users across UK and Ireland
Of 5,000 chronic pain sufferers who reported outcomes:
65% showed 57% average pain reduction
67% of opioid users reduced or discontinued medication
84% reported improved quality of life
93% confirmed long-term effectiveness
Additional Indications Studied
Plantar Fasciitis: Multicenter, double-blind trial showed overnight use reduced heel pain (Journal of Foot and Ankle Surgery)
Italian carpal tunnel study (published 3-2-25):
Results - All patients showed an improvement in pain level and functional capacity after using ActiPatch for pillar pain management. Additionally, none of the patients experienced pillar pain during the subsequent preventive phase.
Conclusion - The use of ActiPatch proves to be a viable and effective approach for managing and preventing pillar pain in elderly patients with weight-bearing hands who have undergone carpal tunnel release surgery.
Bottom Line
PEMF therapy continues to show strong promise for arthritis, including knee, neck, and potentially thumb CMC joints. ActiPatch remains a cost-effective, wearable option with well-established safety and efficacy across trials. For those seeking deeper tissue effects or specialized programs, alternatives like FlexPulse or NeoRhythm may offer additional value.
How ActiPatch Compares to Other PEMF Devices
ActiPatch ($30–$50)
Wearable, low-intensity PEMF device
Frequency: 1 kHz pulses at 27.12 MHz
Intensity: Very low (microtesla range)
Use Case: Chronic pain, arthritis, plantar fasciitis
Pros:
FDA-cleared for musculoskeletal pain
Affordable and easy to use
Long battery life (up to 720 hours)
Cons:
Limited intensity and depth of penetration
Disposable after battery life ends
FlexPulse ($500–$700)
Localized PEMF device with multiple frequency programs
Frequency Range: 0.5 Hz to 100 Hz
Intensity: Up to 300 Gauss
Pros:
Customizable for different conditions
Rechargeable and portable
Stronger electromagnetic field allows deeper tissue penetration
Cons:
Higher cost
Requires setup and understanding of its programming options
Oska Pulse ($300–$400)
Wearable PEMF device with a single automated healing program
Frequency: Varies through four stages
Intensity: ~9 Gauss
Pros:
Easy, one-button operation
Addresses inflammation, pain, blood flow, and healing
Registered as a medical device in multiple countries
Cons:
Lower intensity than FlexPulse
Pricier than ActiPatch
NeoRhythm ($300–$400)
Head-worn PEMF device focused on neurological health
Use Case: Sleep, focus, meditation, cognitive enhancement
Pros:
Controlled via mobile app with multiple brainwave frequency programs
Innovative design for cognitive support
Cons:
Not ideal for musculoskeletal pain
May be uncomfortable to wear while sleeping
1
